Clinical Nutrition Market size was valued at USD 33.09 billion in 2024 and is expected to reach USD 63.96 billion by 2037, expanding at around 5.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of clinical nutrition is assessed at USD 34.47 billion.
The increasing prevalence of metabolic disorders globally, along with the growing investment in the healthcare expenditure are expected to fuel the development of this market. The growth of the market can also be attributed to factors such as the increasing geriatric population and rising middle-class population in emerging economies on a global level. According to the data collected from the United Nations Department of Economic and Social Affairs, in 2020, the estimated elderly population aged above 65 accounted for 727 million and by 2050 the number is expected to get double to approximately 1,500 million.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.2% |
|
Base Year Market Size (2024) |
USD 33.09 billion |
|
Forecast Year Market Size (2037) |
USD 63.96 billion |
|
Regional Scope |
|
The market is segmented based on product into infant nutrition, parenteral nutrition, and enteral nutrition, out of which, the infant nutrition segment is anticipated to grab the largest share by the end of 2029 on account of increased number of malnourished babies and growing premature births. Moreover, increasing government approval of new infant nutrition products globally is also projected to contribute to the growth of the segment during the forecast period.
On the basis of application, the cancer segment in the global clinical nutrition market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that cancer patients are suffering from nutritional deficiency that arises due to various cancer treatments including radiation therapy, chemotherapy, stem cell transplant, and others. As a result, a considerable portion of the population with cancer on a global level is expected to drive the growth of the market over the forecast period.
Based on end-user, the paediatric segment holds the largest share in the global clinical nutrition market on the back of growing concerns and awareness for malnutrition.
Our in-depth analysis of the global market includes the following segments
|
By Products |
|
|
By Application |
|
|
By End-User |
|
APAC Market Statistics
North America industry is anticipated to hold largest revenue share of 33% by 2037, owing to increasing birth rates, and rising geriatric population in the region.
North America Market Analysis
Furthermore, the market in North America is evaluated to occupy the largest share in terms of revenue during the forecast period, owing to the growing healthcare investment, accompanied by the presence of leading healthcare service providers, and the increasing number of chronic disorders in the region. Along with this, the countries in North America, such as the United States, are promoting nutritional care for cancer patients, which is also expected to contribute to the market growth in the region. According to the report published by the National Cancer Institute, in 2020, 1.8 million new cancer cases were registered in the United States. Such increasing rate of cancer is further expected to drive the demand for clinical nutritional products in the North American countries.
Alternatively, the market in Europe is also anticipated to occupy a significant share in the global clinical nutrition market on account of its proven success in terms of technology development and a high prevalence of cancer in the region. As per the analysis of the European Society for Medical Oncology, 2.7 million new cancer cases were registered in the European Union, with 1.3 million deaths in 2020.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?